Related Experiment Video
Updated: Jun 2, 2026

14:04
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Review of a three-year meticillin-resistant Staphylococcus aureus screening programme.
1Department of Microbiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, UK. jennifer.collins@nuth.nhs.uk
The Journal of Hospital Infection
|April 22, 2011
Summary
Newcastle Hospitals NHS Foundation Trust
Area of Science:
- Healthcare Management
- Infectious Disease Control
- Clinical Microbiology
Background:
- Meticillin-resistant Staphylococcus aureus (MRSA) poses a significant healthcare challenge.
- The Department of Health, England mandated universal MRSA screening for all patients.
- Newcastle upon Tyne Hospitals NHS Foundation Trust (NuTH) initiated a seek and destroy (S&D) program in 2006.
Purpose of the Study:
- To evaluate the effectiveness and cost-efficiency of NuTH's MRSA S&D program.
- To compare a targeted S&D approach with universal MRSA screening.
- To determine optimal screening strategies for MRSA reduction.
Main Methods:
- Analysis of 168,073 patient screening results from NuTH's S&D program.
- Utilized chromogenic culture method for MRSA detection in nose, throat, and perineum samples.
- Compared MRSA detection rates and laboratory costs between targeted and universal screening.
Main Results:
- Screening all three sites (nose, throat, perineum) is necessary for maximal MRSA recovery.
- MRSA detection rates did not increase despite increased workload from universal screening inclusion.
- A targeted S&D approach identified only seven fewer day-case MRSA carriers per month compared to universal screening, at a lower cost.
Conclusions:
- A clinical risk-based screening strategy is more pragmatic and cost-effective than universal MRSA screening.
- Universal screening may lead to unnecessary costs and increased laboratory workload without significant gains in MRSA detection.
- NuTH's S&D program demonstrates the value of targeted screening in managing MRSA.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...